Category: Urology

Clinical Correlations

Breaking News: The Downfall of the PSA

The United States Preventive Services Task Force stands their ground in this week’s Annals of Internal Medicine and recommends against the routine use of the PSA as a screening tool for prostate cancer. This Class D recommendation is grounded in data that suggests a “very small” mortality benefit at the …

Read More

Prostate Cancer and Antioxidants

Heme/Onc Urology 4 min read

Commentary by Christopher Tully MD, PGY-1

Faculty Peer Reviewed

An apple a day. . . keeps the prostate cancer away? While it is an overstatement to say that an apple can prevent cancer, the notion of taking “something” to prevent cancer initiation and growth is nothing new. Primary prevention has …

Read More

Breaking News: USPSTF Issues New Prostate Cancer Screening Guidelines

Commentary by Cara Litvin MD, Executive Editor, Clinical Correlations

The US Preventive Services Task Force issued new guidelines for prostate cancer screening on Monday.  For the first time, the task force recommends AGAINST routine screening in patients over 75 years of age, citing the “moderate to substantial” harms over small to no benefits from screening. …

Read More